US4883788A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and composition for reducing serum cholesterol
Assignee: HAUSER - KUHRTS Inc
•
Filing: 1988-09-23
•
Granted: 1989-11-28
•
Expires: 2008-09-23
Abstract
Abstract An orally administrable composition and method for reducing serum cholesterol levels are disclosed. A pharmaceutical composition comprising guar gum, and a dispersing mineral salt such as, for example, calcium carbonate, magnesium carbonate, or potassium carbonate, is administered to humans to reduce serum cholesterol levels.
Inventors
- 👤 Charles E. Day
- 👤 Eric H. Kuhrts
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 19:28
CPC Classifications
A; A61; A61K; A61K36/00; A61K36/18; A61K36/185; A61K36/48
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
68 words
An orally-administrable pharmaceutical composition for use in reducing serum cholesterol levels consisting essentially of: (a) an effective amount of guar gum which exhibits cholesterol-reducing activity, and (b) a dispersibility-enhancing amount of an orally-ingestible non-toxic pharmacologically-acceptable mineral salt capable of dissolution in the gastric fluid with release of a gas, the ratio of guar gum to said mineral salt being in the range of approximately 3:1 to approximately 10:1.
Claim 2
Dependent Claim
68 words
An orally-administrable pharmaceutical composition for use in reducing serum cholesterol levels consisting essentially of: (a) an effective amount of guar gum which exhibits cholesterol-reducing activity, and (b) a dispersibility-enhancing amount of an orally-ingestible non-toxic pharmacologically-acceptable mineral salt capable of dissolution in the gastric fluid with release of a gas, the ratio of guar gum to said mineral salt being in the range of approximately 3:1 to approximately 10:1.
Claim 3
Dependent Claim
13 words
A composition according to claim 1 further comprising a flavorant, sweetener or preservative.
Claim 4
Dependent Claim
24 words
A composition according to claim 1 wherein said mineral salt is selected from the group consisting of calcium carbonate, magnesium carbonate and potassium carbonate.
Claim 5
Independent Claim
66 words
A method for lowering serum cholesterol in humans consisting essentially of administering in an oral dosage unit an effective amount of guar gum and a dispersibility-enhancing amount of an orally ingestible non-toxic pharmacologically-acceptable mineral salt capable of dissolution in the gastric fluid with release of a gas, the ratio of guar gum to said mineral salt being in the range of approximately 3:1 to approximately 10:1.
Claim 6
Independent Claim
66 words
A method for lowering serum cholesterol in humans consisting essentially of administering in an oral dosage unit an effective amount of guar gum and a dispersibility-enhancing amount of an orally ingestible non-toxic pharmacologically-acceptable mineral salt capable of dissolution in the gastric fluid with release of a gas, the ratio of guar gum to said mineral salt being in the range of approximately 3:1 to approximately 10:1.
Claim 7
Dependent Claim
26 words
The method according to claim 4 wherein said salt is a mineral carbonate selected from the group consisting of calcium carbonate, magnesium carbonate, and potassium carbonate.
Claim 8
Dependent Claim
18 words
The method according to claim 4 wherein said oral dosage unit also comprises a flavorant, sweetener or preservatives.
Claim 9
Independent Claim
65 words
A method for lowering serum cholesterol consisting essentially of administering, in an oral dosage unit, an effective amount of guar gum and a dispersibility-enhancing amount of an orally-ingestible, non-toxic, pharmacologically-acceptable mineral carbonate compound capable of dissolution in human gastric fluid with release of a gas, the ratio of said guar gum to said carbonate compound being in the range of approximately 3:1 to approximately 10:1.
Claim 10
Independent Claim
65 words
A method for lowering serum cholesterol consisting essentially of administering, in an oral dosage unit, an effective amount of guar gum and a dispersibility-enhancing amount of an orally-ingestible, non-toxic, pharmacologically-acceptable mineral carbonate compound capable of dissolution in human gastric fluid with release of a gas, the ratio of said guar gum to said carbonate compound being in the range of approximately 3:1 to approximately 10:1.
References Cited (Backward Citations)
US4747881A
Cited
US4764374A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-11-27 | 1993-05-29 | 1993-11-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-11-27 | 1997-05-29 | 1997-11-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-11-27 | 2001-05-29 | 2001-11-28 | $7700.00 | Window Closed / Lapsed |